UnitedHealth Rebound Gains Traction on Earnings Recovery

UnitedHealth's shares are rebounding after showing early signs of stabilizing operating performance. The company reported $112 billion in Q2 revenue and adjusted earnings of $6.38 per share, with full-year adjusted earnings guidance raised to $19.50, $20 per share.

The medical-care ratio improved to 86.7%, and UnitedHealthcare's operating margin rebounded as insurance operations began to recover from elevated claims costs. The company faces pressure from high medical costs, which weigh on the broader health insurance sector.

UnitedHealth trades at about 18 times forward earnings and is still roughly 20% below its 52-week high. Despite this, the stock's valuation is improving due to its increasing dividend yield of 2.5%. The company has raised its dividend for 16 consecutive years with a 10% five-year CAGR.

Investors remain cautious as medical-cost inflation remains a central risk for UnitedHealth and peers like CVS-owned Aetna, which also flag continuing pressure in their insurance operations.